Literature DB >> 26470622

Laser and light-based treatment options for hidradenitis suppurativa.

Iltefat H Hamzavi1, James L Griffith2, Farhaad Riyaz2, Schapoor Hessam3, Falk G Bechara3.   

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory disease that commonly develops painful, deep dermal abscesses and chronic, draining sinus tracts. Classically, pharmacologic and surgical therapies have been effective for reducing lesion activity and inflammation, but provide only modest success in the prevention of future recurrences and disease progression. Adjunctive therapies, such as laser and light-based therapies, have become more commonly used in the management of HS. These therapies work to reduce the occurrence of painful HS flare-ups by decreasing the number of hair follicles, sebaceous glands, and bacteria in affected areas, and by ablatively debulking chronic lesions. The best results are seen when treatment is individualized, taking disease severity into consideration when selecting specific energy-based approaches. This article will discuss various light-based therapies and the evidence supporting their use in the management of HS.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  excision; hair reduction; hidradenitis suppurativa; laser; light

Mesh:

Year:  2015        PMID: 26470622     DOI: 10.1016/j.jaad.2015.07.050

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Impact of 970 nm photobiomodulation therapy on wound healing in cellular models of hidradenitis suppurativa.

Authors:  Luisa Zupin; Giulia Ferri; Paola Maura Tricarico; Rossella Gratton; Cécile Nait-Meddour; Giulia Ottaviani; Sergio Crovella
Journal:  Lasers Med Sci       Date:  2020-07-09       Impact factor: 3.161

2.  Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.

Authors:  Claudia J Posso-De Los Rios; Akua Sarfo; Mondana Ghias; Raed Alhusayen; Iltefat Hamzavi; Michelle A Lowes; Afsaneh Alavi
Journal:  Exp Dermatol       Date:  2019-04-29       Impact factor: 3.960

3.  Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017.

Authors:  Eran Shavit; Afsaneh Alavi; Falk G Bechara; Richard G Bennett; Marc Bourcier; Ricardo Cibotti; Steven Daveluy; John W Frew; Amit Garg; Iltefat Hamzavi; Lauren K Hoffman; Jenny Hsaio; Joslyn Sciacca Kirby; Hadar Lev-Tov; Erin Martinez; Robert Micheletti; Haley B Naik; Aude Nassif; Cynthia Nicholson; Angie Parks-Miller; Zarine Patel; Vincent Piguet; Mayur Ramesh; Barry Resnik; Christopher Sayed; Gregory Schultz; Aamir Siddiqui; Jerry Tan; Ximena Wortsman; Michelle A Lowes
Journal:  Exp Dermatol       Date:  2019-01       Impact factor: 3.960

4.  LAight® Therapy Improves Hidradenitis Suppurativa in Patients Declining Surgical Intervention: Two Case Reports.

Authors:  Izak Johannes Bisschoff; Daniela Kasche; Uwe Kirschner; Piotr K Krajewski; Łukasz Matusiak; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2020-06-18       Impact factor: 3.875

5.  Secondary prevention of hidradenitis suppurativa.

Authors:  Hjalmar Kurzen; Marina Kurzen
Journal:  Dermatol Reports       Date:  2019-10-25

6.  Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients.

Authors:  Gabriella Fabbrocini; Katlein França; Torello Lotti; Claudio Marasca; Maria Carmela Annunziata; Sara Cacciapuoti; Anna Masarà; Marco Romanelli; Jacopo Lotti; Uwe Wollina; Georgi Tchernev; Nicola Zerbinati
Journal:  Open Access Maced J Med Sci       Date:  2018-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.